5,898
Views
11
CrossRef citations to date
0
Altmetric
Articles

An overview of recent developments in metabolomics and proteomics – phytotherapic research perspectives

, , , , &
Pages 1-37 | Received 19 Jul 2016, Accepted 03 Jan 2017, Published online: 21 Feb 2017

References

  • Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature. 422:198–207.
  • Aharoni A, Ric DV, Verhoeven HA, Maliepaard C, Kruppa G, Bino RJ. 2002. Nontargeted metabolome analysis by use of Fourier transform ion cyclotron mass spectrometry. OMICS. 6:217–234.
  • Akhtar MT, Bin Mohd Sarib MS, Ismail IS, Abas F, Ismail A, Lajis NH, Shaari K. 2016. Anti-Diabetic activity and metabolic changes induced by Andrographis paniculata plant extract in obese diabetic rats. Molecules. 21:1026.
  • Al-Zuaidy MH, Hamid AA, Ismail A, Mohamed S, Razis A, Faizal A, Mumtaz MW, Salleh SZ. 2016. Potent antidiabetic activity and metabolite profiling of Melicope Lunu-ankenda Leaves. J food Sci. 81:C1080–C1090.
  • Amacher DE, Adler R, Herath A, Townsend RR. 2005. Use of proteomic methods to identify serum biomarkers associated with Rat liver toxicity or hypertrophy. Clin Chem. 51:1796–1803.
  • Anderson PE, Reo NV, DelRaso NJ, Doom TE, Raymer ML. 2008. Gaussian binning: A new kernel-based method for processing NMR spectroscopic data for metabolomics. Metabolomics. 4:261–272.
  • Asche CV, McAdam-Marx C, Shane-McWhorter L, Sheng X, Plauschinat CA. 2008. Association between oral antidiabetic use, adverse events and outcomes in patients with type 2 diabetes. Diabetes Obes Metab. 10:638–645.
  • Bai X, Qu J, Lu J, Kano Y, Yuan D. 2011. Isolation and identification of urinary metabolites of kakkalide in rats. J Chromatogr B. 879:395–402.
  • Bair Eric Hastie T, Debashis P, Tibshirani R. 2006. Prediction by supervised principal components. J Amer Statist Assoc. 101:119–137.
  • Bajad S, Shulaev V. 2011. LC-MS-based metabolomics. Methods Mol Biol. 708:213–228.
  • Bastaki S. 2005. Diabetes mellitus and its treatment. Int J Diabetes Metab. 13:111–134.
  • Beckwith-Hall BM, Nicholson JK, Nicholls AW, Foxall PJD, Lindon JC, Connor SC, Abdi M, Connelly J, Holmes E. 1998. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem Res Toxicol. 11:260–272.
  • Beger RD, Sun J, Schnackenberg LK. 2010. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol. 243:154–166.
  • Bertol E, Vaiano F, Milia MGD, Mari F. 2015. In vivo detection of the new psychoactive substance AM-694 and its metabolites. Forensic Sci Int. 256:21–27.
  • Betancourt A, Mobley JA, Wang J, Jenkins S, Chen D, Kojima K, Russo J, Lamartiniere CA. 2014. Alterations in the rat serum proteome induced by prepubertal exposure to bisphenol a and genistein. J Proteome Res. 13:1502–1514.
  • Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GH. 1999. Antitumor sterols from the mycelia of cordyceps sinensis. Phytochemistry. 51:891–898.
  • Bony NF, Libong D, Solgadi A, Bleton J, Champy P, Malan AK, Chaminade P. 2014. Establishing high temperature gas chromatographic profiles of non-polar metabolites for quality assessment of African traditional herbal medicinal products. J Pharm Biomed Anal. 88:542–551.
  • Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HWL, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ. 2002. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 8:1439–1445.
  • Cajka T, Vaclavikova M, Dzuman Z, Vaclavik L, Ovesna J, Hajslova J. 2014. Rapid LC–MS-based metabolomics method to study the Fusarium infection of barley. J Sep Sci. 37:912–919.
  • Cao J, Shen H-M, Wang Q, Qian Y, Guo H-C, Li K, Qiao X, Guo Z-A, Luo X-D, Ye M. 2015. Characterization of chemical constituents and rats metabolitesof an alkaloidal extract of Alstonia scholaris leaves by liquidchromatography coupled with mass spectrometry. J Chromatogr B. 19545:1–13.
  • Çelebier M, Simól C, Altınöz S, Cifuentes A. 2015. Comparative proteomics to investigate the in vitro antiproliferative effect of dietary polyphenols against K562 leukemia cells. Turk J Biochem. 40:95–104.
  • Chen D-Q, Chen H, Chen L, Tang D-D, Miao H, Zhao Y-Y. 2016. Metabolomic application in toxicity evaluation and toxicological biomarker identification of natural product. Chem Biol Interact. 252:114–130.
  • Chen H, Chen L, Tang DD, Chen DQ, Miao H, Zhao YY, Ma SC. 2016. Metabolomics reveals hyperlipidemic biomarkers and antihyperlipidemic effect of Poria cocos. Curr Metabolomics. 4:104–115.
  • Chen H-J, Shen Y-C, Shiao Y-J, Liou K-T, Hsu W-H, Hsieh P-H, Lee C-H, Chen Y-R, Lin Y-L. 2015. Multiplex brain proteomic analysis revealed the molecular therapeutic effects of Buyang Huanwu decoction on cerebral ischemic stroke mice. PLoS ONE. 10:1–27.
  • Chen H, Yuan B, Miao H, Tan Y, Bai X, Zhao YY, Wang Y. 2015. Urine metabolomics reveals new insights into hyperlipidemia and the therapeutic effect of rhubarb. Anal. Methods. 7:3113–3123.
  • Connor SC, Wu W, Sweatman BC, Manini J, Haselden JN, Crowther DJ, Waterfield CJ. 2004. Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers. 9:156–179.
  • Cook R, Hennell JR, Lee S, Khoo CS, Carles MC, Higgins VJ, Govindaraghavan S, Sucher NJ. 2013. The Saccharomyces cerevisiae transcriptome as a mirror of phytochemical variation in complex extracts of Equisetum arvense from America, China, Europe and India. BMC Genomics. 14:445–418.
  • Cox DG, Oha J, Keasling A, Colson KL, Hamann MT. 2014. The utility of metabolomics in natural product and biomarker characterization. Biochim. Biophys. Acta. 1840:3460–3474.
  • Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, Westler WM, Eghbalnia HR, Sussman MR, Markley JL. 2008. Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol. 26:162–164.
  • Davis MA, Hinerfeld D, Joseph S, Hui Y-H, Huang NH, Leszyk J, Rutherford-Bethard J, Tam SW. 2006. Proteomic analysis of rat liver phosphoproteins after treatment with protein kinase inhibitor H89 (N-(2-[p-bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide). J Pharmacol Exp Ther. 318:589–595.
  • Davis RA, Charlton AJ, Godward J, Jones SA, Harrison M, Wilson JC. 2007. Adaptive binning: An improved binning method for metabolomics data using the undecimated wavelet transform. Chemometr. Intell Lab Syst. 85:144–154.
  • Deenen MJ, Cats A, Beijnen JH, Schellens JH. 2011a. Part 3: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism. Oncologist. 16: 820–834.
  • Deenen MJ, Cats A, Beijnen JH, Schellens JH. 2011b. Part 3: pharmacogenetic variability in phase II anticancer drug metabolism. Oncologist. 16:992–1005.
  • Dekant W. 2009. The role of biotransformation and bioactivation in toxicity. EXS. 99:57–86.
  • De Meyer T, Sinnaeve D, Van Gasse B, Tsiporkova E, Rietzschel ER, De Buyzere ML, Gillebert TC, Bekaert S, Martins JC, Van Criekinge W. 2008. NMR-based characterization of metabolic alterations in hypertension using an adaptive, intelligent binning algorithm. Anal Chem. 80:3783–3790.
  • Dettmer K, Aronov PA, Hammock BD. 2007. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 26:51–78.
  • Devenport NA, Blenkhorn DJ, Weston DJ, Reynolds JC, Creaser CS. 2014. Direct determination of urinary creatinine by reactive-thermal desorption-extractive electrospray-ion mobility-tandem mass spectroscopy. Anal Chem. 86:357–361.
  • Dona AC, Kyriakides M, Scott F, Shephard EA, Varshavi D, Veselkov K, Everett JR. 2016. A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments. Comput Struct Biotechnol J. doi:10.1016/j.csbj.2016.02.005.
  • Dudzik D, Revello R, Barbas C, Bartha JL. 2015. LC–MS-based metabolomics identification of novel biomarkers of chorioamnionitis and its associated perinatal neurological damage. J Proteome Res. 14:1432–1444.
  • Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. 2011. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 40:387–426.
  • Dutta S, Dey P, Chaudhuri TK. 2014. Phytochemical investigation and correlation study of Croton bonplandianus Baill stem. J Pharmacogn Phytochem. 3:142–148.
  • Edlund U, Grahn H. 1991. Multivariate data analysis of NMR data. J Pharm Biomed Anal. 9:655–658.
  • Emwas AH, Luchinat C, Turano P. 2015. Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics. 11:872–894.
  • Emwas AH, Roy R, McKay RT. 2016. Recommendations and standardization of biomarker quantification using NMR-based metabolomics with particular focus on urinary analysis. J Proteome Res. 15:360–373.
  • Eriksson L, Hagberg P, Johansson E, Rannar S, Whelehan O. 2001. Multivariate process monitoring of a newsprint mill. Application to modelling and predicting COD load resulting from de-inking of recycled paper. J Chemometr. 15:337–352.
  • Fan X, Li X, Lv S, Wang Y, Zhao Y, Luo G. 2010. Comparative proteomics research on rat MSCs differentiation induced by Shuanglong Formula. J Ethnopharmacol. 131:575–580.
  • Fenselau C. 2007. A review of quantitative methods for proteomic studies. J Chromatogr B. Analyt Technol Biomed Life Sci. 855:14–20.
  • Ferber G. 2002. Biomarkers and proof of concept. Methods Find Exp Clin Pharmacol. 24:35–40.
  • Fiehn O. 2002. Metabolomics – the link between genotypes and phenotypes. Plant Mol Biol. 48:155–171.
  • Firouzi Z, Lari P, Rashedinia M, Ramezani M, Iranshahi M, Abnous K. 2014. Proteomics screening of molecular targets of curcumin in mouse brain. Life Sci. 98:12–17.
  • Frank R, Hargreaves R. 2003. Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov. 2:566–580.
  • Frederich M, Pirotte B, Fillet M, Tullio P. 2016. Metabolomics as a challenging approach for medicinal chemistry and personalized medicine. J Med Chem. 59:8649–8666.
  • Freitas DS, Carlos EF, Gil MCSS, Vieira LGE, Alcantara GB. 2015. NMR-based metabolomic analysis of huanglongbing-asymptomatic and-symptomatic citrus trees. J Agric Food Chem. 63:7582–7588.
  • Garcia A, Barbas C. 2011. Gas chromatography-mass spectrometry (GC-MS)-based metabolomics. Methods Mol Biol. 708:191–204.
  • García-Figueiras R, Baleato-González S, Padhani AR, Oleaga L, Vilanova JC, Luna A, Gómez JCC. 2016. Proton magnetic spectroscopy in oncology: the fingerprints of cancer. Diagn Interv Radiol. 22:75–89.
  • Gavaghan CL, Wilson ID, Nicholson JK. 2002. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett. 530:191–196.
  • Gika HG, Theodoridis GA, Plumb RS, Wilson RD. 2014. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J Pharm Biomed Anal. 87:12–25.
  • Giorgi A, Marinis PD, Granelli G, Chiesa LM, Panseri S. 2013. Secondary metabolite profile, antioxidant capacity, and mosquito repellent activity of Bixa orellana from Brazilian Amazon region. J Chem. 2013:1–10.
  • Gorg A, Postel W, Gunther S. 1988. Two-dimensional electrophoresis with immobilized pH gradients of leaf proteins from Barley (hordeum vulgare): method, reproducibility and genetic aspects. Electrophoresis. 9:531–546.
  • Griffin JL, Williams HJ, Sang E, Nicholson JK. 2001. Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning 1H NMR spectroscopy. Magn Reson Med. 46:249–255.
  • Guido RVC, Oliva G. 2009. Structure-based drug discovery for tropical diseases. Curr Top Med Chem. 9:824–843.
  • Hagel JM, Mandal R, Han B, Han J, Dinsmore DR, Borchers CH, Wishart DS, Facchini PJ. 2015. Metabolome analysis of 20 taxonomically related benzylisoquinoline alkaloid-producing plants. BMC Plant Biol. 15:1–17.
  • Hamad I, Abd Elgawad H, Al Jaouni S, Zinta G, Asard H, Hassan S, Hegab M, Hagagy N, Selim S. 2015. Metabolic analysis of various date palm fruit (Phoenix dactylifera L.) cultivars from Saudi Arabia to assess their nutritional quality. Molecules. 20:13620–13641.
  • Han H, Yang L, Xu Y. 2011. Identification of metabolites of geniposide in rat urine using ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Rapid Commun Mass Spectrom. 25:3339–3350.
  • Herbert RB. 1989. The biosynthesis of secondary metabolites. 2nd ed. Brossura: Chapman and Hall. ISBN: 10: 0412277204.
  • Hird SJ, Lau BPY, Schuhmacher R, Krska R. 2014. Liquid chromatography-mass spectrometry for the determination of chemical contaminants in food. TrAC – Trend Anal Chem. 59:59–72.
  • Holmes E, Nicholls AW, Lindon JC, Ramos S, Spraul M, Neidig P. 1998. Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 11:235–244.
  • Horai H, Arita M, Kanaya S, Nihei Y, Ikeda T, Suwa K, Ojima Y, Tanaka K, Tanaka S, Aoshima K, et al. 2010. Massbank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom. 45:703–714.
  • Huang G, Chen H, Zhang X, Cooks RG, Ouyang Z. 2007. Rapid screening of anabolic steroids in urine by reactive desorption electrospray ionization. Anal Chem. 79:8327–8332.
  • Hussain MA, Huygens F. 2012. Proteomic and bioinformatics tools to understand virulence mechanisms in Staphylococcus aureus. Current Proteomics. 9:2–8.
  • Imperiale A, Moussallieh FM, Roche P. 2015. Metabolome profilling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications. Neoplasia. 17:55–65.
  • Jacob D, Deborde C, Moing A. 2013. An efficient spectra processing method for metabolite identification from 1H-NMR metabolomics data. Anal Bioanal Chem. 405:5049–5061.
  • Ji Q, Zhu F, Liu X, Li Q, Su S-B. 2015. Recent advance in applications of proteomics technologies on traditional Chinese medicine research. Evid Based Complement Alternat Med. 2015:1–13.
  • Jia J, Zhang F, Li Z, Qin X, Zhang L. 2015. Comparison of fruits of forsythia suspensa at two different maturation stages by NMR-based metabolomics. Molecules. 20:10065–10081.
  • Jiang T, Wang Z, Shenren Xia T, Zhao X, Jiang L, Teng L. 2015. Quantitative proteomics analysis for effect of Acanthopanax senticosus extract on neuroinflammation. Pak J Pharm Sci. 28:313–318.
  • Karthik D, Ilavenil S, Kaleeswaran B, Ravikumar S. 2012. Analysis of modification of liver proteome in diabetic rats by 2D lectrophoresis and MALDI-TOF-MS. Ind J Clin Biochem. 27:221–230.
  • Karthik D, Vijayakumar R, Pazhanichamy K, Ravikumar S. 2014. A proteomics approach to identify the differential protein level in cardiac muscle of diabetic rat. Acta Biochim Pol. 61:285–293.
  • Kawanishi H, Toyo’oka T, Ito K, Maeda M, Hamada T, Fukushima T, Kato M, Inagaki S. 2007. Hair analysis of histamine and several metabolites in C3H/HeNCrj mice by ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry (UPLC–ESI-TOF-MS): influence of hair cycle and age. Clin Chim Acta. 378:122–127.
  • Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, et al. 2009. The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Targeted Oncol. 4:235–252.
  • Kelly RT, Page JS, Zhao R. 2008. Capillary-based multi nanoelectrospray emitters: improvements in Ion transmission efficiency and implementation with capillary reversed-phase LC-ESI-MS. Anal Chem. 80:143–149.
  • Kim HJ, Cho CW, Hwang JT, Son N, Choi JH, Shim GS, Han CK. 2013. LC-MS based metabolomic analysis of serum and livers from red ginseng-fed. J Ginseng Res. 37:371–378.
  • Kim EJ, Kwon J, Park SH, Park C, Seo Y-B, Shin X, Kim HK, Lee K-S, Choi S-Y, Ryub DH, Hwang G-S. 2011. Metabolite profiling of angelica gigas from different geographical origins using 1H NMR and UPLC-MS analyses. J Agric Food Chem. 59:8806–8815.
  • Kim JA, Nagappan A, Park HS, Saralamma VVG, Hong GE, Yumnam S, Lee HJ, Raha S, Kim EH, Young PS, Kim GS. 2014. Proteome profiling of lipopolysaccharide inducedL6 rat skeletal muscle cells response to flavonoids from Scutellaria baicalensis Georgi. BMC Complement Altern Med. 14:1–10.
  • Kirschenlohr HL, Griffin JL, Clarke SC, Rhydwen R, Grace AA, Schofield PM, Brindle KM, Metcalfe JC. 2006. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med. 12:705–710.
  • Klavins K, Chu DB, Hann S, Koellensperger G. 2014. Fully automated on-line two-dimensional liquid chromatography in combination with ESI MS/MS detection for quantification of sugar phosphates in yeast cell extracts. Analyst. 139:1512–1520.
  • Kovacs H, Moskau D, Spraul M. 2005. Cryogenically cooled probes- a leap in NMR technology. Prog Nucl Mag Res Sp. 46:131–155.
  • Krishan P, Kruger NJ, Ratcliffe RG. 2004. Metabolite fingerprinting and profiling in plants using NMR. J Exp Bot. 56:255–265.
  • Kumar PJ, Clark M. 2002. Textbook of clinical medicine. London: Saunders; p. 1099–1121.
  • Lambert J, Mazzola E. 2004. Nuclear magnetic resonance spectroscopy: an introduction to principles, applications and experimental methods. NJ: Pearson Education Inc.
  • Lao Y, Wang X, Xu N, Zhang H, Xu H. 2014. Application of proteomics to determine the mechanism of action of traditional Chinese medicine remedies. J Ethnopharmacol. 155:1–8.
  • Le Blanc JC, Hager JW, Ilisiu AM, Hunter C, Zhong F, Chu I. 2003. Unique scanning capabilities of a new hybrid linear ion trap mass spectrometer (Q TRAP) used for high sensitivity proteomics applications. Proteomics. 3:859–869.
  • Lee T-Y, Chang H-H, Kuo J-J, Shen J-J. 2009. Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang. Int J Mol Med. 23:477–484.
  • Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AF. 2003. A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal. 33:1103–1115.
  • Lenz EM, Wilson ID. 2007. Analytical strategies in metabonomics. J Proteome Res. 6:443–458.
  • Lesiak AD, Musah RA, Cody RB, Domin MA, Dane AJ, Shepard JR. 2013. Direct analysis in real time mass spectrometry (DART-MS) of “bath salt” cathinone drug mixtures. Analyst. 138:3424–3432.
  • Li Y, Cai W, Cai Q, Che Y, Zhao B, Zhang J. 2016. Comprehensive characterization of the in vitro and in vivo metabolites of geniposide in rats using ultra-high-performance liquid chromatography coupled with linear ion trap–orbitrap mass spectrometer. Xenobiotica. 46:357–368.
  • Li Z, Chen K, Guo M, Tang D. 2016. Two-dimensional liquid chromatography and its application in traditional Chinese medicine analysis and metabonomic investigation. J Sep Sci. 39:21–37.
  • Li F, Gonzalez FJ, Ma X. 2012. LC–MS-based metabolomics in profiling of drug metabolism and bioactivation. Acta Pharmaceutica Sinica B. 2:118–125.
  • Li Z, Song X, Fu Z, Wu B, Ling Y, Sun Z, Chen M, Xu D, Huang H. 2013. Identification of the major constituents in Zhimu–Huangqi. herb-pair extract and their metabolites in rats by LC–ESI-MSn. Chromatographia. 76:767–780.
  • Liang Y, Hao H, Xie L, Kang A, Xie T, Zheng X, Dai C, Hao K, Sheng L, Wang G. 2010. Development of a systematic approach to identify metabolites for herbal homologs based on liquid chromatography hybrid Ion trap time-of-flight mass spectrometry: gender-related difference in metabolism of Schisandra lignans in rats. Drug Metab Dispos. 38:1747–1759.
  • Lindberg G, Lindblad U, Melander A. 2004. Sulfonylureas for treating type 2 diabetes mellitus. Cochrane Database Syst Rev. 3:254.
  • Lindon JC, Nicholson JK. 2008. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem. 1:45–69.
  • Liu P, Duan J-A, Guo J-M, Shang E-X, Qian D-W, Su S-L, Tang Y-P. 2013. Identification of major chemical constituents and their metabolites In Rat plasma And various organs after oral administration Of effective Xiang–Fu–Si–Wu decoction fraction By uplc-Q-Tof-Ms And metabolynx. J Liq Chromatogr Relat Tech. 36:1736–1749.
  • Liu Z, Huang J, Huo Y, Gong J, Zhang Y, Wei C, Pu J. 2015. Identification of proteins implicated in the increased heart rate in ShenSongYangXin-treated bradycardia rabbits by iTRAQ-based quantitative proteomics. Evid Based Complement Alternat Med. 2015:1–7.
  • Liu Y, Song F, Wu WKK, He M, Zhao L, Sun X, Li H, Jiang Y, Yang Y, Peng K. 2012. Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3epsilon. Cell Biochem Func. 30:271–278.
  • Lu C-L, Qv X-Y, Jiang J-G. 2010. Proteomics and syndrome of Chinese medicine. J Cell Mol Med. 14:2721–2728.
  • Lu Z, Song Q, Yang J, Zhao X, Zhang X, Yang P, Kang J. 2014. Comparative proteomic analysis of anti- cancer mechanism by periplocin treatment in lung cancer cells. Cell Physiol Biochem. 33:859–868.
  • Lu X, Zhao X, Bai C, Zhao C, Lu G, Xu G. 2008. LC–MS-based metabonomics analysis. J Chromatogr B. 866:64–76.
  • Lynn K-S, Cheng M-L, Chen Y-R, Hsu C, Chen A, Lih TM, Chang H-Y, Huang C-J, Shiao M-S, Pan W-H, et al. 2015. Metabolite identification for mass spectrometry-based metabolomics using multiple types of correlated Ion information. Anal Chem. 87:2143–2151.
  • Madsen R, Lundstedt T, Trygg J. 2010. Chemometrics in metabolomics-A review in human disease diagnosis. Anal Chim Acta. 659:23–33.
  • Mahrous EA, Farag MA. 2015. Two dimensional NMR spectroscopic approaches for exploring plant metabolome: A review. J Adv Res. 6:3–15.
  • Maitra S, Yan J. 2008. Principal Component Analysis and Partial Least Squares: Two Dimension Reduction Techniques for Regression. Casualty Actuarial Society. Discussion Paper Program, p. 79–90.
  • Manavalan A, Ramachandran U, Sundaramurthi H, Mishra M, Sze SK, Hu JM, Feng ZW, Heese K. 2012. Gastrodia elata Blume (tianma) mobilizes neuro-protective capacities. Int J Biochem Molecular Biol. 3:219–241.
  • Merrick BA, Bruno ME, Madenspacher JH, Wetmore BA, Foley J, Pieper R, Zhao M, Makusky AJ, McGrath AM, Zhou JX, et al. 2006. Alterations in the Rat serum proteome during liver injury from acetaminophen exposure. J Pharmacol Exp Ther.. 318:792–802.
  • Meyer GMJ, Maurer HH. 2015. In vivo and in vitro metabolism studies of glaucine, a new herbal high by GC-MS, LC-MS, LC-HR-MS, and NMR techniques. Toxichem Krimtech. 82:323.
  • Miao H, Zhao YH, Vaziri ND, Tang DD, Chen H, Chen H, Khazaeli M, Tarbiat-Boldaji M, Hatami L, Zhao YY. 2016. Lipidomics biomarkers of diet-induced hyperlipidemia and Its treatment with Poria cocos. J Agric Food Chem. 64:969–979.
  • Min JZ, Yano H, Matsumoto A, Yu HF, Shi Q, Higashi T, Inagaki S, Toyo’oka T. 2011. Simultaneous determination of polyamines in human nail as 4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole derivatives by nano-flow chip LC coupled with quadrupole time-of-flight tandem mass spectrometry. Clin Chim Acta. 412:98–106.
  • Moran A, Palmas W, Field L. 2004. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care. 27:972–977.
  • Na DH, Ji HY, Park EJ, Kim MS, Liu KH, Lee HS. 2011. Evaluation of metabolism-mediated herb–drug interactions. Arch Pharm Res. 34:1829–1842.
  • Nagai T, Nakao M, Shimizu Y, Kodera Y, Oh-Ishi M, Maeda T, Yamada H. 2011. Proteomic analysis of anti-inflammatory effects of a Kampo (Japaneseherbal) medicine “Shoseiryuto (Xiao–Qing–Long–Tang)” on airway inflammation in a mouse model. J Evid Based Complementary Altern Med. 2011. Article ID 604196.
  • Nicholson JK, Connelly J, Lindon JC, Holmes E. 2002. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 1:153–161.
  • Nicholson JK, Lindon JC, Holmes E. 1999. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29:1181–1189.
  • Nkomo M, Katerere DR, Vismer HF, Cruz T, Balayssac S, Malet-Martino M, Makunga NP. 2014. Fusarium inhibition by wild populations of the medicinal plant salvia africana-lutea L. linked to metabolomic profiling. BMC Complement Altern Med. 14:99. doi:doi: 10.1186/1472-6882-14-99.
  • Noda I. 2014. Frontiers of two-dimensional correlation spectroscopy. Part 1. New concepts and noteworthy developments. J Mol Struct. 1069:3–22.
  • Olokoba AB, Obateru OA, Olokoba LB. 2012. Type 2 diabetes mellitus: A review of current trends. Oman Med J. 27:269–273.
  • Patwardhan B, Vaidya AD. 2010. Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. Indian J Exp Biol. 48:220–227.
  • Pereira VP, Knor FJ, Vellosa JCR, Beltrame FL. 2014. Determination of phenolic compounds and antioxidant activity of green, black and white teas of Camellia sinensis (L.) Kuntze, Theaceae. Rev Bras Pl Med. 16:490–498.
  • Popescu R, Costinel D, Dinca OR, Marinescu A, Stefanescu I, Ionete RE. 2015. Discrimination of vegetable oils using NMR spectroscopy and chemometrics. Food Control. 48:84–90.
  • Prasad B, Garg A, Takwani H, Singh S. 2011. Metabolite identification by liquid chromatography-mass spectrometry. Trend Anal Chem. 30:360–387.
  • Prasad B, Singh S. 2010. Identification of rat urinary metabolites of rifabutin using LC–MSn and LC–HR-MS. Eur J Pharm Sci. 41:173–188.
  • Priori R, Casadei L, Valerio M, Scrivo R, Valesini G, Manetti C. 2015. 1H-NMR-BasedMetabolomic study for identifying serum profiles associated with the response to etanercept in patients with rheumatoid arthritis. PLoS ONE. 10:1–14.
  • Qiao X, Wang Q, Ji Q, Huang Y, Liu K, Zhang Z-X, Bo T, Tzeng Y-M, Guo D-A, Ye M. 2015. Metabolites identification and multi-component pharmacokinetics of ergostane and lanostane triterpenoids in the anticancer mushroom Antrodia cinnamomea. J Pharm Biomed Anal. 111:266–276.
  • Qing J, Fangshi Z, Xuan L, Qi L, Shi-bing S. 2015. Recent advance in applications of proteomics technologies on traditional Chinese medicine research. J Evid Based Complementary Altern Med. 2015:1–10.
  • Quang DN, Bach DD. 2008. Ergosta-4,6,8(14), 22-tetraen-3-one from Vietnamese Xylaria sp. possessing inhibitory activity of nitric oxide production. Nat Prod Res. 22:901–906.
  • Rainville PD, Stumpf CJ, Shockcor JP, Plumb RS, Nicholson JK. 2007. Novel application of reversed-phase UPLC–oaTOFMS for lipid analysis in complex biological mixture: a new tool for lipidomics. J Proteome Res. 6:552–558.
  • Ravi KC, Henry ID, Park GHK, Raftery D. 2009. Design and construction of a versatile dual volume heteronuclear double resonance microcoil NMR probe. J Magn Reson. 197:186–192.
  • Riaz S. 2015. Study of protein biomarkers of diabetes mellitus type 2 and therapy with vitamin B1. J Diabetes Res. 2015:1–10.
  • Robertson D, Lindon J, Nicholson JK, Holmes E. 2005. Metabonomics in toxicity assessment. Boca Raton, FL: CRC Press.
  • Rokaya MB, Uprety Y, Poudel RC, Timsina B, Münzbergová Z, Asselin H, Tiwari A, Shrestha SS, Sigdel SR. 2014. Traditional uses of medicinal plants in gastrointestinal disorders in Nepal. J Ethnopharmacol. 158:221–229.
  • Roscioli KM, Tufariello JA, Zhang X, Li SX, Goetz GH, Cheng G, Siems WF, Hill HH Jr. 2014. Desorption electrospray ionization (DESI) with atmospheric pressure ion mobility spectrometry for drug detection. Analyst. 139:1740–1750.
  • Rosipal Roman Krämer N. 2006. Overview and recent advances in partial least squares. In: Saunders C, et al. editor. Subspace, latent structure and feature selection, Vol. 3940. Heidelberg: Springer-Verlag; p. 34–51.
  • Roskar R, Lusin TT. 2012. Analytical methods for quantification of drug metabolites in biological samples. In: Calderon, L, editor. Chromatography - the most versatile method of chemical analysis. InTech. doi:doi: 10.5772/51676.
  • Roux A, Lison D, Junot C, Heilier JF. 2011. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clin Biochem. 44:119–135.
  • Rooney OM, Troke J, Nicholson JK, Griffin JL. 2003. High resolution diffusion and relaxation-edited magic angle spinning 1HNMR spectroscopy of intact liver tissue. Magn Reson Med. 50:925–930.
  • Schaper JN, Pfeuffer KP, Shelley JT, Bings NH, Hieftje GM. 2012. Drop on demand sample introduction system coupled with the flowing atmospheric-pressure after glow for direct molecular analysis of complex liquid microvolume samples. Anal Chem. 84:9246–9252.
  • Scognamiglio M, Abrosca BD, Esposito A, Fiorentino A. 2015. Chemical composition and seasonality of aromatic Mediterranean plant species by NMR-based metabolomics. J Anal Meth Chem. 2015:1–9.
  • Sharge L, Yu A. 1999. Applied biopharmaceutics and pharmacokinetics. 4th ed. McGraw-Hill.
  • Shi J, Cao B, Wang X-W, Aa J-Y, Duan J-A, Zhu X-X, Wang G-J, Liu C-X. 2016. Metabolomics and its application to the evaluation of the efficacy and toxicity of traditional Chinese herb medicines. J Chromatogr B. 1026:204–216.
  • Shi X, Lu XG, Zhan LB, Qi X, Liang LN, Hu SY, Yan Y, Zhao SY, Sui H, Zhang FL. 2011. The effects of the Chinese medicine Zi Bu Pi Yin recipe on the hippocampus in a rat model of diabetes-associated cognitive decline: a proteomic analysis. Diabetologia. 54:1888–1899.
  • Shobha A, Sachin D, Awanish U, Rakesh YS, Rahul P, Alka B. 2012. Identification of prednisolone, methylprednisolone and their metabolites in human urine using HPLC (+) ESI-MS/MS and detection of possible adulteration in Indian herbal drug preparations. Ibnosina J Med BS. 4:44–52.
  • Smith CA, O’Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G. 2005. METLIN: a metabolite mass spectral database. Ther Drug Monit. 27:747–751.
  • Sousa SAA, Magalhães A, Ferreira MMC. 2013. Optimized bucketing for NMR spectra: three case studies. Chemometr. Intell Lab Syst. 122:93–102.
  • Sulistio YA, Heese K. 2015. Proteomics in traditional Chinese medicine with an emphasis on Alzheimer’s disease. J Evid Based Complementary Altern Med. 2015:1–17.
  • Sun H. 2004. A universal molecular descriptor system for prediction of LogP, LogS, LogBB, and absorption. J Chem Info and Comput Sci. 44:748–757.
  • Sun X-G, Zhong X-L, Liu Z-F, Cai H-B, Fan Q, Wang Q-R, Liu Q, Song Y-H, He S-Q, Zhang X-F, Lu Z-P. 2010. Proteomic analysis of chronic restraint stress-induced Gan-stagnancy syndrome in rats. Chin J Integr Med. 16:510–517.
  • Svensson M, Eriksson JW, Dahlquist G. 2004. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care. 27:955–962.
  • Syka JE, Marto JA, Bai DL, Horning S, Senko MW, Schwartz JC, Ueberheide B, Garcia B, Busby S, Muratore T, et al. 2004. Novel linear quadrupole ion trap/FT mass spectrometer: performance characterization and use in the comparative analysis of histone H3 post-translational modifications. J Proteome Res. 3:621–626.
  • Taamalli A, Arráez-Román D, Abaza L, Iswaldi I, Fernández-Gutiérrez A, Zarrouk M, Segura-Carretero A. 2015. LC-MS-basedmetabolite profiling of methanolic extracts from the medicinal and aromatic species Mentha pulegium and Origanum majorana. Phytochem Anal. 26:320–330.
  • Tagore S, Chowdhury N, De RK. 2014. Analyzing methods for pathmining with applications in metabolomics. Gene. 534:125–138.
  • Tam JCW, Ko CH, Zhang C, Wang H, Lau CP, Chan WY, Leung PC, Fung KP, Zhang JF, Lau CBS. 2014. Comprehensive proteomic analysis of a Chinese 2-herb formula (Astragali Radix and Rehmanniae Radix) on mature endothelial cells. Proteomics. 14:2089–2103.
  • Tang H, Wang Y, Nicholson JK, Lindon JC. 2004. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small molecules in blood plasma. Anal Biochem. 325:260–272.
  • Tao LM, Fang L, Yang YM, Jiang HL, Yang HY, Zhang H, Zhou H. 2013. Quantitative proteomic analysis reveals the neuro protective effects of huperzine A for amyloid beta treated neuro blastoma N2a cells. Proteomics. 13:1314–1324.
  • Theodoridis G, Gika HG, Wilson ID. 2008. LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. Trend Anal Chem. 27:251–260.
  • Tsogtbaatar E, Cocuron J-C, Sonera MC, Alonso AP. 2015. Metabolite fingerprinting of pennycress (Thlaspi arvense L.) embryos to assess active pathways during oil synthesis. J Exp Bot. 2015:1–11.
  • Tsugawa H, Tsujimoto Y, Arita M, Bamba T, Fukusaki E. 2011. GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of a class analogy (Simca). BMC Bioinformatics. 12:1–13.
  • Uarrota VG, Moresco R, Coelho B, Nunes EC, Peruch LAM, Neubert EO, Rocha M, Maraschin M. 2014. Metabolomics combined with chemometric tools (PCA, HCA, PLS-DA and SVM) for screening cassava (Manihot esculenta Crantz) roots during postharvest physiological deterioration. Food Chem. 161:67–78.
  • Vaidyanathan S, Harrigan GG, Goodacre R. 2005. Metabolome analyses: strategies for systems biology. New York: Springer.
  • Versace F, Sporkert F, Mangin P, Staub C. 2012. Rapid sample pre-treatment prior to GC-MS and GC-MS/MS urinary toxicology screening. Talanta. 101:299–306.
  • Vu TN, Laukens K. 2013. Getting your peaks in line: A review of alignments methods for NMR spectral data. Metabolites. 3:259–276.
  • Wang H, Bai X, Sun J, Kano Y, Makino T, Yuan D. 2013. Metabolism and excretion of kakkalide and its metabolites in rat urine, bile, and feces as determined by HPLC/UV and LC/MS/MS. Planta Med. 79:1552–1557.
  • Wang J, Betancourt AM, Mobley JA, Lamartiniere CA. 2011. Proteomic discovery of genistein action in the rat mammary gland. J Proteomic Res. 10:1621–1631.
  • Wang SY, Li J, Shi XZ, Qiao LZ, Lu X, Xu GW. 2013. A novel stop-flow two-dimensional liquid chromatography–mass spectrometry method for lipid analysis. J Chromatogr A. 1321:65–72.
  • Wang D, Park JS, Chu JS, Krakowski A, Luo K, Chen DJ, Li S. 2004. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta-1 stimulation. J Biol Chem. 279:43725–43734.
  • Wang XJ, Yan GL, Zhang AH, Sun H, Piao CY, Li WY, Sun C, Wu XH, Li XH, Chen Y. 2013. Metabolomics and proteomics approaches to characterize and assess proteins of bear bile powder for hepatitis C virus. Chin J Nat Med. 11:653–665.
  • Want EJ, Wilson ID, Gika H, Theodoridis G, Plumb RS, Shockcor J, Holmes E, Nicholson JK. 2010 Global metabolic profiling procedures for urine using UPLC–MS. Nat Protoc. 5:1005–1018.
  • Williams DA. 2002. Drug metabolism. In: Troy D, editor. Foye’s principles of medicinal chemistry. 5th ed. Baltimore: Lippincott Williams & Wilkins; p. 174–233.
  • Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, et al. 2013. HMDB 3.0 – the human metabolome database in 2013. Nucleic Acids Res. 41:D801–D807.
  • Woldegiorgis AZ, Abate D, Haki GD, Ziegler GR. 2015. LC-MS/MS based metabolomics to identify biomarkers unique to laetiporus sulphureus. Int J Nut Food Sci. 4:141–153.
  • Wright MH, Sieber SA. 2016. Chemical proteomics approaches for identifying the cellular targets of natural products. Nat Prod Rep. 33:681–708.
  • Wu X, Li N, Li H, Tang H. 2014. An optimized method for NMR-based plant seed metabolomic analysis with maximized polar metabolite extraction efficiency, signal-to-noise ratio, and chemical shift consistency. Analyst. 139:1769–1778.
  • Wu H, Li X, Yan X, An L, Luo K, Shao M, Jiang Y, Xie R, Feng F. 2015. An untargeted metabolomics-driven approach based on LC–TOF/MSand LC–MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma. J Pharm Biomed Anal. 115:315–322.
  • Yang Q, Shi XZ, Wang Y, Wang WZ, He HB, Lu X, Xu GW. 2010. Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system. J Sep Sci. 33:1495–1503.
  • Yao M, Ma L, Duchoslav E, Zhu M. 2009. Rapid screening and characterization of drug metabolites using multiple ion monitoring dependent product ion scan and postacquisition data mining on a hybrid triple quadrupole-linear ion trap mass spectrometer. Rapid Commun Mass Spectrom. 23:1683–1693.
  • Ye L, Tang L, Gong Y, Lv C, Zheng Z, Jiang Z, Liu Z. 2011. Characterization of metabolites and human P450 isoforms involved in the microsomal metabolism of mesaconitine. Xenobiotica. 41:46–58.
  • Ye NS, Chen J, Luo GA, Zhang RL, Zhao YF, Wang YM. 2006. Proteomic profiling of rat bone marrow mesenchymal stem cells induced by 5-azacytidine. Stem Cells Dev. 15:665–676.
  • Ye NS, Zhang RL, Zhao YF, Feng X, Wang YM, Luo GA. 2006. Effect of 5-azacytidine on the protein expression of porcine bone marrow mesenchymal stem cells in vitro. Genomics Proteomics Bioinformatics. 4:18–25.
  • Yue QX, Xie FB, Song XY, Wu WY, Jiang BH, Guan SH, Yang M, Liu X, Guo DA. 2012. Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemicreperfusion injury. J Ethnopharmacol. 141:659–667.
  • Zhang J-M, Fu C-M, Hu Y-C, Li Y, Qing S-H, Gao F. 2012. Screening out potential cardio-toxic components of Chinese herb radix aconiti lateralis in rat dosed plasma by high performance liquid hromatography/electrospray ionization quadrupole time-of-flight mass spectrometry. Anal Lett. 45:1695–1712.
  • Zhang H, Ge Y. 2011. Comprehensive analysis of protein modifications by top-down mass spectrometry. Circ Cardiovasc Gen. 4:1–21.
  • Zhang G, Qia W, Xu L, Kano Y, Yuan D. 2015. Pharmacokinetics of irisolidone and its main metabolites in ratplasma determined by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B. 1005:23–29.
  • Zhang W, Saif MW, Dutschman GE, Li X, Lama W, Bussoma S, Jiang Z, Yea M, Chub E, Cheng YC. 2010. Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS). J Chromatogr A. 1217:5785–5793.
  • Zhang S-X, Sun H, Sun W-J, Jiao G-Z, Wang X-J. 2010. Proteomic study of serum proteins in a type 2 diabetes mellitus rat model by Chinese traditional medicine Tianqi Jiangtang capsule administration. J Pharm Biomed Anal. 53:1011–1014.
  • Zhang A, Sun H, Yan G, Wang P, Wang X. 2015. Metabolomics for biomarker discovery: moving to the clinic. BioMed Res Int. 2015:1–6.
  • Zhang ZH, Vaziri ND, Wei F, Cheng XL, Bai X, Zhao YY. 2016. An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of rheum officinale in chronic renal failure. Scient Rep. 6:1–18.
  • Zhang ZH, Wei F, Vaziri ND, Cheng XL, Bai X, Lin RC, Zhao YY. 2015. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Scient Rep. 5:1–17.
  • Zhao Y-Y. 2013. Metabolomics in chronic kidney disease. Invited Crit Rev Clin Chim Acta. 422:59–69.
  • Zhao YY, Chen H, Tian T, Chen DQ, Bai X, Wei F. 2014. A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMS. Plos One. 9:1–18.
  • Zhao YY, Cheng XL, Cui JH, Yan XR, Wei FR, Bai XU, Lin RC. 2012. Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: A serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clin Chim Acta. 413:1438–1445.
  • Zhao Y-Y, Cheng X-L, Vaziri ND, Liu S, Lin R-C. 2014. UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clin Biochem. 47:16–26.
  • Zhao YY, Cheng XL, Wei F, Bai X, Lin RC. 2012. Ultra performance liquid chromatography coupled with electrospray and atmospheric pressure chemical ionization-quadrupole time-of-flight mass spectrometry with novel mass spectrometry elevated energy data collection technique: determination and pharmacokinetics, tissue distribution and biliary excretion study of ergone in rat. J Sep Sci. 35:1619–1629.
  • Zhao YY, Feng YL, Bai X, Tan XJ, Lin RC, Mei Q. 2013. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One. 8:1–10.
  • Zhao YY, Lei P, Chen DQ, Feng YL, Bai X. 2013. Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE. J Pharm Biomed Anal. 81–82:202–209.
  • Zhao YY, Li HT, Feng YL, Bai X, Lin RC. 2013. Urinary metabonomic study of the surface layer of poria cocos as an effective treatment for chronic renal injury in rats. J. Ethanopharmacol. 148:403–410.
  • Zhao Y-Y, Lin R-C. 2014. UPLC–MSE application in disease biomarker discovery: The discoveries in proteomics to metabolomics-mini review. Chem Biol Int. 215:7–16.
  • Zhao YY, Shen X, Cheng XL, Feng W, Bai XU, Lin RC. 2012. Urinary metabonomics study on the protective effects of ergosta-4,6,8(14),22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MSE data collection technique. Process Biochem. 47:1980–1987.
  • Zhao YY, Su Q, Cheng XL, Tan XJ, Bai X, Lin RC. 2012. Pharmacokinetics, bioavailability, and metabolism of rhaponticin in rat plasma by UHPLC–Q-TOF/MS and UHPLC–DAD-MSn. Bioanalysis 4:713–723.
  • Zhao YY, Zhang L, Feng YL, Chen D-Q, Xi ZH, Du X, Bai X, Lin R-C. 2013. Pharmacokinetics of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside in rat using ultra-performance LC–quadrupole TOF-MS. J Sep Sci. 36:863–871.
  • Zhao YY, Zhang L, Long FY, Cheng XL, Bai X, Wei F, Lin RC. 2013. UPLC-Q-TOF/HSMS/MS(E)-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one. Chem Biol Interact. 201:31–38.
  • Zhao YY, Zhao Y, Zhang YM, Lin RC, Sun WJ. 2009. Qualitative and quantitative analysis of the diuretic component ergone in polyporus umbellatus by HPLC with fluorescence detection and HPLCAPCI-MS/MS. Pharmazie. 64:366–370.
  • Zhou YC, Liu B, Li YJ, Jing LL, Wen G, Tang J, Xu X, Lv ZP, Sun XG. 2012. Effects of buyang huanwu decoction on ventricular remodeling and differential protein profile in a rat model of myocardial infarction. Evid Based Complementary Alternat Med. 2012:1–11.
  • Zhou B, Xiao JF, Tuli L, Ressom HW. 2012. LC-MS-based metabolomics. Mol Biosyst. 8: 470–481.